InsidersTradesSigma
Browse the complete record of transactions filed by SAHNI PAYAL, Chairman & CEO. Officer active across 1 company, notably PFIZER INC. Cumulatively, 3 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €68k. History available since 23 February 2022. The latest transaction was filed on 13 May 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations
Payal Sahni is the President and Chief Executive Officer of Pfizer Inc. She oversees the company's global operations, focusing on innovation and research in the pharmaceutical sector. With a strong background in management and strategy, she is committed to advancing Pfizer's mission to improve the health and well-being of patients worldwide.